| Authors: |
Anil A; From the Cancer System Imaging (A.A., C.C.Q.), The University of Texas MD Anderson Cancer Center, Houston, Texas., Stokes AM; Division of Neuroimaging Research and Barrow Neuroimaging Innovation Center (A.M.S.), Barrow Neurological Institute, Phoenix, Arizona., Karis JP; Department of Neuroradiology (J.P.K.), Barrow Neurological Institute, Phoenix, Arizona., Bell LC; Clinical Imaging Group (L.C.B.), Genentech Inc., San Francisco, California., Eschbacher J; Department of Neuropathology (J.E.), Barrow Neurological Institute, Phoenix, Arizona., Jennings K; Department of Biostatistics (K.J.), The University of Texas MD Anderson Cancer Center, Houston, Texas., Prah MA; Department of Biophysics (M.A.P., K.M.S.), Medical College of Wisconsin, Milwaukee, Wisconsin., Hu LS; Department of Radiology (L.S.H.), Division of Neuroradiology, Mayo Clinic Arizona, Phoenix, Arizona., Boxerman JL; Department of Diagnostic Imaging (J.L.B.), Rhode Island Hospital, Providence, Rhode Island., Schmainda KM; Department of Biophysics (M.A.P., K.M.S.), Medical College of Wisconsin, Milwaukee, Wisconsin., Quarles CC; From the Cancer System Imaging (A.A., C.C.Q.), The University of Texas MD Anderson Cancer Center, Houston, Texas ccquarles@mdanderson.org. |
